Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Food “superallergies”: the first Italian study proves that they can be cured with the incriminated allergen

10.03.2008
By setting an alimentary desensitization protocol against milk and egg proteins, the medical team of the Pediatric Clinic of the University of Trieste, located at the Institute of Child Health Burlo Garofolo, has demonstrated the possibility to reeducate the organism of “superallergic” children to accept incriminated foods without suffering from severe, and occasionally lethal reactions such as anaphylaxis or edema of the glottidis.

The study – directed by professor Alessandro Ventura, Director of the Clinic – lasted three years, at the end of which 36% of the children involved, once severely allergic with important, generalized reactions to even minimal contact with the dangerous food, and therefore life threatened, has re-achieved the ability to follow a normal diet without presenting any adverse reactions. On the other hand, 54% of the patients involved in the study were able to tolerate minimal quantities of the incriminated food in their diet.

With this experimental work, recently published by the Journal of Allergy and Clinical Immunology, the researchers confirmed the validity of a face-to-face direct approach to severe food allergies that the Burlo Garofolo has been persecuting since long, in countertrend to the majority of the allegologists that limit the treatment of severe food allergies to strict elimination of the harmful food from the diet. In Europe, allergies to specific foods such as milk or egg proteins are on the up. In Italy, at least 400,000 children aged 5 - 15 suffer from this disorder, and 3000 are at risk of severe reactions for minimal contact with the allergen.

The protocol – Sixty Italian children, classified as “superallergic” to milk or eggs according to the severity of the symptoms, were selected and involved in the study. “The desensitization schedule is articulated in two parts – explains Giorgio Longo, Director of the Allergology Department of the Burlo Garofolo – the first one, where there is a major risk of severe reactions, lasts 10 days and takes place in the Hospital. During the hospitalization, milk is administered at rapidly increasing doses, at two hours intervals, until at discharge the child is able to intake 10 to 20 ml of pure milk”. The second part takes place at home, with the cooperation of the parents that, according to a scheme provided by the doctors continue the administration of milk, once a day, at a much slower and gradual rate of increase. In doing so the child is able to tolerate ever increasing doses of milk, until he or she is able to follow a completely normal diet. The positive result (recovery) is usually obtained within a year.

The results – One third of the treated patients now eats freely, whatever he or she feels like. Half of them have not reached a normal diet yet, but are able to introduce significant quantities of milk without showing any adverse reaction. 10% of the treated patients did not respond positively to the treatment, and despite all the attempts, keep on to presenting important adverse reactions.

Are there any risks with this strategy? “We did not have any lethal cases. However, desensitization can be accompanied by some complications – confirms Egidio Barbi from the Pediatric Clinic, available 24 hours a day for emergencies that might occur during the home phase of the protocol. “However, given the potential benefits, it’s a risk worth to be taken. The protective strategy, i.e. the elimination of the incriminated food, is dangerous as well: statistically, even children who intentionally avoid the dangerous food occasionally come across the allergen during the 5 years following the onset of the diet. Usually, these patients develop very severe reactions.”

Cristina Serra | alfa
Further information:
http://www.burlo.trieste.it

More articles from Health and Medicine:

nachricht Routing gene therapy directly into the brain
07.12.2017 | Boston Children's Hospital

nachricht New Hope for Cancer Therapies: Targeted Monitoring may help Improve Tumor Treatment
01.12.2017 | Berliner Institut für Gesundheitsforschung / Berlin Institute of Health (BIH)

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

Im Focus: Successful Mechanical Testing of Nanowires

With innovative experiments, researchers at the Helmholtz-Zentrums Geesthacht and the Technical University Hamburg unravel why tiny metallic structures are extremely strong

Light-weight and simultaneously strong – porous metallic nanomaterials promise interesting applications as, for instance, for future aeroplanes with enhanced...

Im Focus: Virtual Reality for Bacteria

An interdisciplinary group of researchers interfaced individual bacteria with a computer to build a hybrid bio-digital circuit - Study published in Nature Communications

Scientists at the Institute of Science and Technology Austria (IST Austria) have managed to control the behavior of individual bacteria by connecting them to a...

Im Focus: A space-time sensor for light-matter interactions

Physicists in the Laboratory for Attosecond Physics (run jointly by LMU Munich and the Max Planck Institute for Quantum Optics) have developed an attosecond electron microscope that allows them to visualize the dispersion of light in time and space, and observe the motions of electrons in atoms.

The most basic of all physical interactions in nature is that between light and matter. This interaction takes place in attosecond times (i.e. billionths of a...

Im Focus: A transistor of graphene nanoribbons

Transistors based on carbon nanostructures: what sounds like a futuristic dream could be reality in just a few years' time. An international research team working with Empa has now succeeded in producing nanotransistors from graphene ribbons that are only a few atoms wide, as reported in the current issue of the trade journal "Nature Communications."

Graphene ribbons that are only a few atoms wide, so-called graphene nanoribbons, have special electrical properties that make them promising candidates for the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

Blockchain is becoming more important in the energy market

05.12.2017 | Event News

 
Latest News

Making fuel out of thick air

08.12.2017 | Life Sciences

Rules for superconductivity mirrored in 'excitonic insulator'

08.12.2017 | Information Technology

Smartphone case offers blood glucose monitoring on the go

08.12.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>